Fmoc-1-Aminocyclopropane-1-carboxylic acid

Fmoc-1-Aminocyclopropane-1-carboxylic acid is an Fmoc-protected amino acid derivative in which the alpha-amino acid motif is constrained within a cyclopropane ring, producing a rigid chiral environment around the stereogenic center at the cyclopropane carbon bearing the carboxylate. The structure combines an Fmoc carbamate on the amino functionality with a carboxylic acid handle, enabling controlled N-protection for peptide coupling while preserving a reactive acid for downstream transformations. Cyclopropane ring strain and conformational restriction can influence amide bond geometry and local backbone presentation, making the building block relevant for stereodefined peptide analogs and conformationally constrained scaffolds. The compound is typically handled as a protected amino acid intermediate compatible with standard peptide synthesis workflows, where orthogonal deprotection and coupling strategies allow incorporation into growing peptide chains.

1. Peptide Synthesis

Fmoc-1-Aminocyclopropane-1-carboxylic acid is used as an Fmoc-protected amino acid building block for solid-phase or solution-phase peptide synthesis where the Fmoc group enables iterative N-terminal protection and deprotection cycles. The cyclopropane-constrained side of the backbone and the free carboxylic acid functionality support formation of amide linkages through standard peptide coupling chemistries, while the rigid ring can modulate local conformational preferences of the resulting peptide. Incorporation of the constrained residue can be applied to generate peptide libraries, mapping how backbone rigidity affects folding propensity, protease recognition, or receptor-binding conformations. The downstream product is a stereodefined peptide intermediate suitable for further functionalization, purification, and structure-activity relationship studies within peptide chemistry.

2. Peptidomimetics Design

Fmoc-1-Aminocyclopropane-1-carboxylic acid serves in peptidomimetic construction where cyclopropane rigidity can be leveraged to emulate or disrupt specific backbone torsions relative to flexible amino acid analogs. The Fmoc-protected amine and carboxylic acid group allow incorporation into peptide-like frameworks that maintain defined stereochemistry at the alpha position, supporting rational scaffold design for conformational control. Strain-induced conformational effects can be exploited when designing constrained analogs for binding-site probing, receptor selectivity mapping, or stability-oriented analog generation without requiring additional side-chain functional groups. The resulting constrained amide-containing structures can be carried forward into medicinal chemistry campaigns as well-defined intermediates for SAR-driven optimization.

3. Chemical Biology Probes

Fmoc-1-Aminocyclopropane-1-carboxylic acid can be applied in chemical biology research to create conformationally constrained peptide probes that interrogate biomolecular recognition events. The Fmoc-protected amine supports sequential peptide assembly, while the carboxylic acid enables controlled derivatization into amide-linked reporter constructs or further functionalized conjugates after peptide incorporation. Cyclopropane constraint may help tune probe residence time on targets by altering backbone presentation, which can be useful when comparing recognition patterns across analog series. The compound thus functions as a stereodefined intermediate for generating peptide-based chemical probes and biomolecule-interacting constructs used in target engagement and interaction mapping workflows.

4. Protein Engineering

Fmoc-1-Aminocyclopropane-1-carboxylic acid is suitable for protein engineering efforts that rely on peptide or protein segment synthesis followed by incorporation of constrained residues. The protected amino acid form supports synthesis of defined peptide fragments containing the cyclopropane motif, which can then be used to assemble larger protein constructs or to generate engineered binding domains for in vitro studies. The constrained ring and stereogenic center can influence secondary structure propensity and local backbone dynamics, enabling systematic evaluation of how rigidity affects protein-ligand or protein-protein interfaces. The downstream utility includes producing sequence-defined intermediates for structural studies and for generating modified protein variants that incorporate noncanonical backbone geometry.

5. Process Chemistry Intermediate

Fmoc-1-Aminocyclopropane-1-carboxylic acid is relevant to process chemistry intermediate preparation for manufacturing workflows that require protected amino acid derivatives with reliable orthogonal behavior. The Fmoc carbamate provides a robust N-protection strategy compatible with common deprotection conditions used in peptide manufacturing, while the carboxylic acid functionality supports conversion into coupling-ready forms during scale-up. Cyclopropane constraint can improve reproducibility of downstream peptide conformation-dependent properties, which is beneficial when producing stereodefined peptide intermediates at larger scale. The compound can therefore be employed as a chiral amino acid intermediate in fine chemical synthesis and specialty chemical production where consistent peptide building block performance is required.

6. Analytical Standards

Fmoc-1-Aminocyclopropane-1-carboxylic acid can be used to prepare analytical standards and reference materials for method development in amino acid and peptide analysis. The presence of a defined Fmoc-protected amino acid scaffold with a cyclopropane-constrained backbone provides a chemically specific marker for monitoring peptide coupling incorporation, deprotection progress, and impurity profiling during peptide synthesis. The carboxylic acid and carbamate functionalities enable derivatization pathways that support LC-MS, HPLC, or capillary electrophoresis method tuning for protected amino acid derivatives and their peptide-related species. The resulting reference compounds support analytical research and quality-oriented characterization across peptide manufacturing and intermediate release testing.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists